Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
CodeAllP: Open-market purchaseS: Open-market saleA: Grant or awardM: Option exerciseF: Tax withholdingG: GiftD: Disposition to issuerC: ConversionX: In-the-money exerciseJ: Other
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | RYES Rise Gold Corp. | Watkinson David George CEO and President | DDisposition to issuer Restricted Stock Units (RSUs)derivative | -62,500 | $0.00 | $0 | 0 | 25 h ago |
| Dec 31, 2024 | CSGS CSG SYSTEMS INTERNATIONAL INC | Shepherd Brian A. President & CEO | DDisposition to issuer Common Stock | -42,135 | $0.00 | $0 | 540,194 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Marissa Solis Michel director | DDisposition to issuer Common Stock, par value $0.01 per share | -87,658 | $4.70 | $412k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | GERKE THOMAS A director | DDisposition to issuer Common Stock, par value $0.01 per share | -173,679 | $4.70 | $816k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Rahe Maribeth S director | DDisposition to issuer Common Stock, par value $0.01 per share | -203,319 | $4.70 | $956k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Udell C Robert JR President & CEO | DDisposition to issuer Common Stock, par value $0.01 per share | -1,539,593 | $4.70 | $7.2M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Graffam Fred Chief Financial Officer | DDisposition to issuer Common Stock, par value $0.01 per share | -304,271 | $4.70 | $1.4M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | CURREY ROBERT J director | DDisposition to issuer Common Stock, par value $0.01 per share | -223,378 | $4.70 | $1.0M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | CURREY ROBERT J director | DDisposition to issuer Common Stock, par value $0.01 per shareindirect: Robert J. Currey, Revocable Trust | -71,793 | $4.70 | $337k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Fuller David G director | DDisposition to issuer Common Stock, par value $0.01 per share | -109,746 | $4.70 | $516k | 0 | Dec 31, 2024 |
| Dec 26, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADL | -50,000 | $9.01 | $451k | 223,512 | Dec 30, 2024 |
| Dec 26, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $9.01 | $451k | 181,443 | Dec 30, 2024 |
| Dec 27, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADL | -50,000 | $8.85 | $443k | 173,512 | Dec 30, 2024 |
| Dec 27, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $8.85 | $443k | 131,443 | Dec 30, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Richieri Richard A. Chief Operations Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -5,043 | $0.00 | $0 | 123,485 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Richieri Richard A. Chief Operations Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -5,044 | $0.00 | $0 | 118,441 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Richieri Richard A. Chief Operations Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -5,652 | $0.00 | $0 | 112,789 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Richieri Richard A. Chief Operations Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -5,652 | $0.00 | $0 | 107,137 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -1,005 | $0.00 | $0 | 74,107 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -1,893 | $0.00 | $0 | 72,214 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -1,908 | $0.00 | $0 | 70,306 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -4,494 | $0.00 | $0 | 65,812 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -6,725 | $0.00 | $0 | 130,568 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -6,725 | $0.00 | $0 | 123,843 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -6,782 | $0.00 | $0 | 117,061 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -6,782 | $0.00 | $0 | 110,279 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -15,972 | $0.00 | $0 | 94,307 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Kwietniak Matthew R. Chief Commercial Officer | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -15,972 | $0.00 | $0 | 78,335 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Restricted Stock Unitsderivative | -4,279 | $0.00 | $0 | 123,096 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -11,208 | $0.00 | $0 | 196,266 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -11,208 | $0.00 | $0 | 185,058 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -11,303 | $0.00 | $0 | 173,755 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -11,304 | $0.00 | $0 | 162,451 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -22,817 | $0.00 | $0 | 139,634 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Hart Daniel R Chief Financial Officer | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -22,818 | $0.00 | $0 | 116,816 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Restricted Stock Unitsderivative | -16,721 | $0.00 | $0 | 466,193 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Restricted Stock Unitsderivative | -26,479 | $0.00 | $0 | 439,714 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Restricted Stock Unitsderivative | -25,434 | $0.00 | $0 | 414,280 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Restricted Stock Unitsderivative | -51,339 | $0.00 | $0 | 362,941 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -47,073 | $0.00 | $0 | 787,310 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2023 Grant)derivative | -47,073 | $0.00 | $0 | 740,237 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -45,215 | $0.00 | $0 | 695,022 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2024 Grant)derivative | -45,215 | $0.00 | $0 | 649,807 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -91,270 | $0.00 | $0 | 558,537 | Dec 27, 2024 |
| Dec 25, 2024 | CDMO Avid Bioservices, Inc. | Green Nicholas Stewart President & CEO | DDisposition to issuer Performance Stock Units (FY 2025 Grant)derivative | -91,270 | $0.00 | $0 | 467,267 | Dec 27, 2024 |
| Dec 20, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADL | -100,000 | $9.00 | $900k | 373,512 | Dec 26, 2024 |
| Dec 20, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -100,000 | $9.00 | $900k | 331,443 | Dec 26, 2024 |
| Dec 23, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADL | -50,000 | $8.52 | $426k | 323,512 | Dec 26, 2024 |
| Dec 23, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $8.52 | $426k | 281,443 | Dec 26, 2024 |
| Dec 24, 2024 | CADL Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo owner | DDisposition to issuer CADL | +50,000 | $8.82 | $441k | 273,512 | Dec 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.